| 000 | 01205 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513111737.0 | ||
| 264 | 0 | _c19970213 | |
| 008 | 199702s 0 0 eng d | ||
| 022 | _a1055-3207 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAugust, D A | |
| 245 | 0 | 0 |
_aTheoretic and experimental aspects of regional liver infusion. _h[electronic resource] |
| 260 |
_bSurgical oncology clinics of North America _cApr 1996 |
||
| 300 |
_a399-409 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChemoembolization, Therapeutic |
| 650 | 0 | 4 | _aChemotherapy, Cancer, Regional Perfusion |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aGelatin Sponge, Absorbable |
| 650 | 0 | 4 | _aHepatic Artery |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xmetabolism |
| 650 | 0 | 4 | _aLiver Circulation |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMicrospheres |
| 650 | 0 | 4 | _aStarch |
| 773 | 0 |
_tSurgical oncology clinics of North America _gvol. 5 _gno. 2 _gp. 399-409 |
|
| 999 |
_c9009600 _d9009600 |
||